Immunogenicity: Clinical Trials

4 trials for Immunogenicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Active not recruiting 1, Recruiting 1

Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults
Standard dose influenza vaccine, MF59 adjuvanted influenza vaccine, High dose influenza vaccine - Influenza Vaccination, Older Adults (65 Years and Older)
Phase 4RecruitingKorea University Guro Hospital1802026-09-212026-09-24
A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia
quadrivalent HPV vaccine - Vaccine Effectiveness, HPV Vaccination
Phase 4Active not recruitingInternational Agency for Research on Cancer12662026-06-012026-10-05
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
CoronaVac - Rheumatic Disease, HIV Infections
Phase 4CompletedUniversity of Sao Paulo General Hospital21962021-02-092024-03-26
Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children
Measles-Rubella (MR) Vaccine - Safety Issues, Immunogenicity
Phase 4CompletedPT Bio Farma5902017-11-162019-09-12

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Arthritis, Rheumatoid (1)  ·  COVID-19 (1)  ·  HIV Infections (1)  ·  Influenza, Human (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Rheumatic Diseases (1)

Broader conditions

Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  Influenza Vaccines (1)  ·  Vaccines (1)  ·  sinovac COVID-19 vaccine (1)

Sponsors

International Agency for Research on Cancer (1)  ·  Korea University Guro Hospital (1)  ·  PT Bio Farma (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  Indonesia (1)  ·  South Korea (1)  ·  Zambia (1)

Top investigators

Dominicus Husada, Dr (1)  ·  Joon Young Song, MD, PhD (1)

Results publications

PMID 34331051, PMID 34664616, PMID 34806342, PMID 34894235, PMID 34901885, PMID 34954325, PMID 35135832, PMID 35193873, PMID 35277389, PMID 35306594, PMID 35639644, PMID 35844042, PMID 36150668, PMID 36192386, PMID 36529052, PMID 36870351, PMID 37291679, PMID 42261247